“…This reduces the production cost while maintaining its functionality (Peterson et al , 2006;Whittington et al , 1998). The use of recombinantly produced single chain variable fragment (scFv) antibodies as immunoassay capture and display biomolecules has generated considerable interest (Dominguez et al , 1999;Giuliani et al , 1989;Jaaskelainen et al , 2008;Luo et al , 1998;Shaw et al , 2008;Shen et al , 2008;Wang et al , 2008). As shown in Fig.…”